Patents by Inventor Minoru Tanaka

Minoru Tanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11186588
    Abstract: The 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivatives or salts thereof of the present invention have BRD4 inhibitory activity, and thus, they are useful as medicaments, in particular, as prophylaxis and/or therapeutic agents for diseases associated with BRD4.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: November 30, 2021
    Assignee: AYUMI PHARMACEUTICAL CORPORATION
    Inventors: Hiroyuki Aono, Iwao Seki, Miwa Imamura, Tomomi Tanaka, Satoshi Shirae, Kenji Kawashima, Yusuke Yamazaki, Minoru Yamamoto
  • Publication number: 20210319608
    Abstract: A transaction processing system of the present disclosure includes processing circuitry configured to acquire image data of an image displayed on a display apparatus for displaying a content of a transaction; extract, from the image data, a character or graphic displayed on the display apparatus; analyze a content represented by the character or graphic; and generate instruction information, based on the analyzed content, for controlling a money processing apparatus to perform processing relating to the transaction.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 14, 2021
    Applicant: Glory Ltd.
    Inventors: Kazuya NISHINO, Yukiya TANAKA, Minoru HIGASHIYAMA
  • Publication number: 20210284654
    Abstract: Provided are a compound superior in a cytotoxic action on cancer cells, an action inducing degradation of BET protein in cancer cells, and an inhibitory action on the binding of BET protein and acetylated histone, and useful as an anticancer agent, a BET protein degradation inducer or a BET protein inhibitor.
    Type: Application
    Filed: July 4, 2019
    Publication date: September 16, 2021
    Applicants: MITSUBISHI TANABE PHARMA CORPORATION, KABUSHIKI KAISHA YAKULT HONSHA
    Inventors: Ryuta YAMAZAKI, Tatsuya IBUKI, Yuichi SAWAGUCHI, Kiyomi OHBA, Maiko HAMADA, Yasuki NIWA, Yuko ISHIDA, Hideto MARUYAMA, Shiki MATSUKI, Minoru TANAKA
  • Publication number: 20210260612
    Abstract: A controller is configured to control a liquid supply to change a landing position of a liquid on a surface of a substrate continuously by discharging the liquid toward the surface of the substrate from a first liquid discharge nozzle while moving the first liquid discharge nozzle. The controller is also configured to derive discharge position deviation information of the liquid supply by comparing first temperature information based on a spot temperature measured by a temperature measurement device when the first liquid discharge nozzle is moved along a first nozzle path and second temperature information based on the spot temperature measured by the temperature measurement device when the first liquid discharge nozzle is moved along a second nozzle path which is different from the first nozzle path.
    Type: Application
    Filed: February 19, 2021
    Publication date: August 26, 2021
    Inventors: Terufumi Wakiyama, Yuichi Douki, Akinori Tanaka, Minoru Tashiro, Reo Kitayama, Shu Yamamoto
  • Publication number: 20210221826
    Abstract: The present invention provides bivalent inhibitors of BET bromodomains, such as compounds of Formulae (I), (II), (III), (IV), (V), and (VI). Some bromodomain-containing proteins (e.g., BRD4) have a tandem bromodomain primary structure comprising more than one bromodomain binding site (e.g., BRD4 comprises BD1 and BD2). Bivalent inhibitors of BET bromodomains provided herein can target bromodomains through advantageous multivalent interactions, and can therefore can be to treat diseases or conditions associated with bromodomain-containing proteins. The present also provides pharmaceutical compositions and kits comprising the inventive compounds, as well as methods of using the inventive compounds.
    Type: Application
    Filed: December 15, 2020
    Publication date: July 22, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka, Justin M. Roberts
  • Publication number: 20210206779
    Abstract: The present invention provides compounds and pharmaceutically compositions thereof. The compounds and compositions are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.
    Type: Application
    Filed: September 9, 2016
    Publication date: July 8, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka, Dennis Buckley
  • Publication number: 20210164284
    Abstract: A cooker with a door includes: a proximity sensor configured to detect presence or absence of an object in proximity to the cooker; and a door opening controller configured to control the door to open and close on a detection signal from the proximity sensor, wherein the door opening controller opens the door when receiving the detection signal from the proximity sensor twice or more within a predetermined time period, the detection signal indicating the presence of the object.
    Type: Application
    Filed: September 14, 2018
    Publication date: June 3, 2021
    Inventors: MINORU TANAKA, KATSUMI ISHIFURO, TOSHIRO MEIJI, JUNICHI TAKEUCHI
  • Publication number: 20210139929
    Abstract: This invention is intended to evaluate smut resistance with higher accuracy using a marker associated with sugarcane smut resistance, which consists of a continuous nucleic acid region existing in a region between the nucleotide sequence as shown in SEQ ID NO: 1 and the nucleotide sequence as shown in SEQ ID NO: 6, a region between the nucleotide sequence as shown in SEQ ID NO: 135 and the nucleotide sequence as shown in SEQ ID NO: 143, or a region between the nucleotide sequence as shown in SEQ ID NO: 144 or 145 and the nucleotide sequence as shown in SEQ ID NO: 151 of a sugarcane chromosome.
    Type: Application
    Filed: July 2, 2019
    Publication date: May 13, 2021
    Applicant: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Masaaki MORI, Tatsuro KIMURA, Hiroyuki ENOKI, Yusuke UETA, Takeo SAKAIGAICHI, Yuke TARUMOTO, Minoru TANAKA, katsuki ADACHI, Taichiro HATTORI, Makoto UMEDA, Michiko HAYANO
  • Publication number: 20210109529
    Abstract: A path generation device is configured to generate a path along which a mobile object is to travel. The device comprises a planner module configured to plan a steering angle and a steering angular velocity for the mobile object to travel from a start position to a goal position by generating first and second isosceles triangles connecting the start position and the goal position based on the start position of the mobile object, a start position traveling direction being a traveling direction of the mobile object at the start position, the goal position of the mobile object, and a goal position traveling direction being a traveling direction of the mobile object at the goal position. The device comprises a curved path applying module configured to apply a first curved path along legs of the first isosceles triangle and apply a second curved path along legs of the second isosceles triangle.
    Type: Application
    Filed: February 21, 2019
    Publication date: April 15, 2021
    Applicant: KABUSHIKI KAISHA TOYOTA JIDOSHOKKI
    Inventors: Yuuji TSUSAKA, Akinobu FUJII, Minoru TANAKA, Shingo HATTORI
  • Publication number: 20210105872
    Abstract: A cooking apparatus includes a display unit and a display control unit configured to control the display unit. The display control unit controls the display unit to display an advertisement at a time when a user is likely to view a display screen of the display unit.
    Type: Application
    Filed: January 10, 2017
    Publication date: April 8, 2021
    Inventors: MINORU TANAKA, KAORI FUJIMOTO, KEISUKE MORISHITA, IKUO TSUZUKI, KAZUNORI YASUDA, HIROKI MORIKAWA, TAMON MOTOYA, KAZUYUKI NAKO
  • Publication number: 20210093644
    Abstract: The present invention provides compounds of Formula (I), and pharmaceutically compositions thereof. Compounds of Formula (I) are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.
    Type: Application
    Filed: September 9, 2020
    Publication date: April 1, 2021
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka
  • Patent number: 10913752
    Abstract: The present invention provides bivalent inhibitors of BET bromodomains, such as compounds of Formulae (I), (II), (III), (IV), (V), and (VI). Some bromdomain-containing proteins (e.g., BRD4) have a tandem bromodomain primary structure comprising more than one bromodomain binding site (e.g., BRD4 comprises BD1 and BD2). Bivalent inhibitors of BET bromodomains provided herein can target bromodomains through advantageous multivalent interactions, and can therefore can be to treat diseases or conditions associated with bromodomain-containing proteins. The present also provides pharmaceutical compositions and kits comprising the inventive compounds, as well as methods of using the inventive compounds.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: February 9, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka, Justin M. Roberts
  • Patent number: 10881668
    Abstract: The present invention provides compounds of Formula (I), and pharmaceutically compositions thereof. Compounds of Formula (I) are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: January 5, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka
  • Patent number: 10850961
    Abstract: A forklift includes: a fork 22, a moving mechanism configured to move the fork in a first direction; a laser sensor 20 mounted on the fork, configured to scan laser light in a second direction intersecting the first direction, and measure a distance from the laser sensor to a surrounding object based on reflection of the scanned laser light; and a processor configured to generate a three-dimensional range image within an emission range to which the laser light is emitted based on distance data acquired when the laser sensor scans the laser light in the second direction while the moving mechanism moves the fork in the first direction.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: December 1, 2020
    Assignee: KABUSHIKI KAISHA TOYOTA JIDOSHOKKI
    Inventors: Minoru Tanaka, Akinobu Fujii, Yuuji Tsusaka, Makoto Ichinose, Makoto Hayakawa
  • Patent number: 10842310
    Abstract: The present invention provides a cooking device (1A) which, in a case where food items are cooked consecutively, makes the cooked food items uniform in condition. The cooking device (1A) includes an upper heater (17), a d lower heater (18), a steam supplying section (20), a temperature sensor (27), and a heating control section (31A). The heating control section (31A) controls, based on the temperature measured by the temperature sensor (27), the operations of the upper heater (17) and the lower heater (18) so that the temperature in a cooking room (14) becomes equal to a given temperature. In a case where the time from the start of a cooking process to the end of the cooking process is divided into a preceding time period and a subsequent time period, the heating control section (31A) suspends the operations of the upper heater (17) and the lower heater (18) while the temperature in the cooking room (14) is higher than a given preceding target temperature (T1) during the preceding time period.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: November 24, 2020
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Kazuya Kitatani, Masayuki Iwamoto, Manami Kobayashi, Rika Nozawa, Keisuke Morishita, Minoru Tanaka
  • Patent number: 10730860
    Abstract: The present invention provides compounds of Formula (II) (e.g., compounds of Formula (I)), and pharmaceutically compositions thereof. Compounds of Formula (II) are believed to be binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: August 4, 2020
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka
  • Publication number: 20200199150
    Abstract: The present invention provides compounds and pharmaceutically compositions thereof. The compounds and compositions are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.
    Type: Application
    Filed: September 9, 2016
    Publication date: June 25, 2020
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka, Dennis Buckley
  • Publication number: 20200172553
    Abstract: The present invention provides bivalent inhibitors of BET bromodomains, such as compounds of Formulae (I), (II), (III), (IV), (V) and (VI). Some bromdomain-containing proteins (e.g., BRD4) have a tandem bromodomain primary structure comprising more than one bromodomain binding site (e.g., BRD4 comprises BD1 and BD2). Bivalent inhibitors of BET bromodomains provided herein can target bromodomains through advantageous multivalent interactions, and can therefore can be to treat diseases or conditions associated with bromodomain-containing proteins. The present also provides pharmaceutical compositions and kits comprising the inventive compounds, as well as methods of using the inventive compounds.
    Type: Application
    Filed: November 23, 2016
    Publication date: June 4, 2020
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: James E. Bradner, Jun Qi, Minoru Tanaka, Justin M. Roberts
  • Patent number: 10574516
    Abstract: A disclosed management apparatus that manages communication in a network shared by information processing apparatuses of plural users includes: a memory and a processor coupled to the memory.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: February 25, 2020
    Assignee: FUJITSU LIMITED
    Inventors: Masanori Kimura, Masakazu Fukaya, Jun Tanaka, Toshio Sugimoto, Minoru Tanaka
  • Publication number: 20200058425
    Abstract: A superconducting coil device (10) includes: a coil case (20) housing a superconducting coil (30); a superconducting coil (30) housed in the coil case (20); and a resin part (50) formed of a polymer (51) filled in a gap between an inner wall of the coil case (20) and the superconducting coil (30). The resin part (50) is formed of a polymer (51) obtained by polymerizing a polymerizable composition containing a first monomer having a norbornene ring structure.
    Type: Application
    Filed: May 10, 2018
    Publication date: February 20, 2020
    Applicants: RAILWAY TECHNICAL RESEARCH INSTITUTE, RIMTEC CORPORATION
    Inventors: Katsutoshi Mizuno, Minoru Tanaka, Masaki Takeuchi